BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 30958912)

  • 1. Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8
    Jin S; Xiang P; Liu J; Yang Y; Hu S; Sheng J; He Q; Yu W; Han W; Jin J; Peng J
    Prostate; 2019 Jun; 79(8):909-919. PubMed ID: 30958912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway.
    Yang Y; Hu S; Liu J; Cui Y; Fan Y; Lv T; Liu L; Li J; He Q; Han W; Yu W; Sun Y; Jin J
    Sci Rep; 2017 Feb; 7():42893. PubMed ID: 28216616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells.
    Ren Y; Zheng J; Yao X; Weng G; Wu L
    Int J Mol Med; 2014 Nov; 34(5):1430-8. PubMed ID: 25244411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
    Li N; Xi Y; Tinsley HN; Gurpinar E; Gary BD; Zhu B; Li Y; Chen X; Keeton AB; Abadi AH; Moyer MP; Grizzle WE; Chang WC; Clapper ML; Piazza GA
    Mol Cancer Ther; 2013 Sep; 12(9):1848-59. PubMed ID: 23804703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
    Shimizu-Albergine M; Rybalkin SD; Rybalkina IG; Feil R; Wolfsgruber W; Hofmann F; Beavo JA
    J Neurosci; 2003 Jul; 23(16):6452-9. PubMed ID: 12878685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the cGMP/PKG/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia.
    Jin S; Liu Z; Xiang P; Fu M; Zhang G; Li J; Niu Y
    World J Urol; 2024 May; 42(1):333. PubMed ID: 38761255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
    Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
    Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE5 modulates oocyte spontaneous maturation via cGMP-cAMP but not cGMP-PKG signaling.
    Wang S; Ning G; Chen X; Yang J; Ouyang H; Zhang H; Tai P; Mu X; Zhou B; Zhang M; Xia G
    Front Biosci; 2008 May; 13():7087-95. PubMed ID: 18508718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
    Castro LR; Schittl J; Fischmeister R
    Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cGMP-enhancing- and alpha1A/alpha1D-adrenoceptor blockade-derived inhibition of Rho-kinase by KMUP-1 provides optimal prostate relaxation and epithelial cell anti-proliferation efficacy.
    Liu CM; Lo YC; Wu BN; Wu WJ; Chou YH; Huang CH; An LM; Chen IJ
    Prostate; 2007 Sep; 67(13):1397-410. PubMed ID: 17639498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.
    Vignozzi L; Gacci M; Cellai I; Morelli A; Maneschi E; Comeglio P; Santi R; Filippi S; Sebastianelli A; Nesi G; Serni S; Carini M; Maggi M
    Prostate; 2013 Sep; 73(13):1391-402. PubMed ID: 23765639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
    Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
    Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low intraprostatic DHT promotes the infiltration of CD8+ T cells in BPH tissues via modulation of CCL5 secretion.
    Fan Y; Hu S; Liu J; Xiao F; Li X; Yu W; Cui Y; Sun M; Lv T; He Q; Jin J
    Mediators Inflamm; 2014; 2014():397815. PubMed ID: 24808637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasia.
    Zenzmaier C; Sampson N; Pernkopf D; Plas E; Untergasser G; Berger P
    Endocrinology; 2010 Aug; 151(8):3975-84. PubMed ID: 20555034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities.
    Corbin JD; Turko IV; Beasley A; Francis SH
    Eur J Biochem; 2000 May; 267(9):2760-7. PubMed ID: 10785399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions.
    Wilson LS; Elbatarny HS; Crawley SW; Bennett BM; Maurice DH
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13650-5. PubMed ID: 18757735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
    Murthy KS
    Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic GMP signaling in rat urinary bladder, prostate, and epididymis: tissue-specific changes with aging and in response to Leydig cell depletion.
    Müller D; Mukhopadhyay AK; Davidoff MS; Middendorff R
    Reproduction; 2011 Aug; 142(2):333-43. PubMed ID: 21511885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo.
    Zhong X; Lin J; Zhou J; Xu W; Hong Z
    Mol Med Rep; 2015 Aug; 12(2):1699-708. PubMed ID: 25825141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract.
    Fibbi B; Morelli A; Vignozzi L; Filippi S; Chavalmane A; De Vita G; Marini M; Gacci M; Vannelli GB; Sandner P; Maggi M
    J Sex Med; 2010 Jan; 7(1 Pt 1):59-69. PubMed ID: 19796053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.